ATLASTenax Therapeutics (TENX) earnings date: Nov 11, 2026
Tenax Therapeutics (TENX) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026. Analysts expect EPS of -$0.35.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TENX
| Last price | $1.80 (+0.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±9.1% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Tenax Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Tenax Therapeutics reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Tenax Therapeutics. You can switch it off at any time.
Alert me before TENX reportsFree to start. Creating an account takes under a minute.
Notify me when Tenax Therapeutics reports
Track TENX free Add Tenax Therapeutics to a free ATLAS watchlist and see its next report date in one place.
TENX earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.35 |
| Last report | Jul 28, 2026 · In line |
| Beat rate (last 3 reports) | 1 of 3 (33%) |
| Average EPS surprise | +2.6% |
| Average move around a report | ±5.9% (last 3) |
| Sector | Healthcare · Biotechnology |
Tenax Therapeutics earnings history: last 3 reports
Tenax Therapeutics last reported on Jul 28, 2026: EPS of $2.84 against an estimate of $2.80 (+1.4% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 28, 2026 | $2.80 | $2.84 | +1.4% | In line | -8.5% |
| May 27, 2026 | $2.91 | $2.90 | -0.3% | In line | -2.4% |
| May 6, 2026 | $2.55 | $2.72 | +6.7% | Beat | -6.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TENX
See the fair value, the probability range and the earnings history of Tenax Therapeutics on its ATLAS page.
Tenax Therapeutics (TENX) stock analysisPlans from €3.99 a month.
Tenax Therapeutics earnings: frequently asked questions
When does Tenax Therapeutics (TENX) report earnings?
Tenax Therapeutics is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for TENX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.35 per share (USD). Estimates can change before the report.
How often does TENX beat earnings estimates?
Of its last 3 reports with a recorded result, Tenax Therapeutics beat the EPS estimate 1 times; the average surprise was +2.6%. Past results do not predict the next one.
How much does TENX move around earnings?
Over its last 3 reports the stock moved an average of 5.9% (absolute, from the close before the report day to the close after it), and finished higher 0 of 3 times.
Did Tenax Therapeutics beat earnings estimates last quarter?
Tenax Therapeutics last reported on Jul 28, 2026: EPS of $2.84 against an estimate of $2.80 (+1.4% surprise), in line with the estimate.
How much does TENX usually move in a day?
On a normal trading day the ATLAS model puts TENX’s one-day range at about ±9.1%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer